Stockreport

Allergan's Bimatoprost ER implant on par with timolol in reducing IOP in late-stage study [Seeking Alpha]

ALLERGAN INC  (AGN) 
Last allergan inc earnings: 2/10 07:00 am Check Earnings Report
US:NYSE Investor Relations: allergan.com/investors
PDF Allergan's Bimatoprost ER implant on par with timolol in reducing IOP in late-stage studyTopline data from a Phase 3 clinical trial assessing the ability of Allergan's ( [Read more]